Patent · US Expired

Multivalent RNA aptamers and their expression in multicellular organisms

US6458559B1 · kind B1 · utility

31Cited by
21References
62Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 22, 1999
Grant dateOct 1, 2002
Priority date
Expiry dateApr 22, 2019

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2510/00
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to a monovalent RNA aptamer that binds to Drosophila splicing factor B52 and a multivalent RNA aptamer that includes at least two RNA aptamer sequences linked together. Also disclosed are isolated or constructed DNA molecules which encode either a monovalent RNA aptamer or a multivalent RNA aptamer of the present invention, an engineered gene encoding a multivalent RNA aptamer of the present invention, and host cells and expression systems which contain either a heterologous DNA molecule or a heterologous gene of the present invention. Further aspects of the present invention relate to a method of expressing a multivalent RNA aptamer in a cell, a method of increasing activity of a splicing factor protein in a cell, and a method of inhibiting activity of a target molecule in a cell. A transgenic non-human organism whose somatic and germ cell lines contain an engineered gene encoding a multivalent RNA aptamer is also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.